Derivation and Application of Molecular Signatures to Prostate Cancer: Opportunities and Challenges

Por Doultsinos, Dimitrios, Mills, Ian G.
Publicado no Cancers (Basel) (2021)

ChIPping away at gene regulation

Por Massie, Charles E, Mills, Ian G
Publicado em 2008

N-Linked Glycosylation Supports Cross-Talk between Receptor Tyrosine Kinases and Androgen Receptor

Por Itkonen, Harri M., Mills, Ian G.
Publicado em 2013

Clathrin Is Spindle-Associated but Not Essential for Mitosis

Por Borlido, Joana, Veltri, Greg, Jackson, Antony P., Mills, Ian G.
Publicado em 2008

Meta-analysis of prostate cancer gene expression data identifies a novel discriminatory signature enriched for glycosylating enzymes

Por Barfeld, Stefan J, East, Philip, Zuber, Verena, Mills, Ian G
Publicado no BMC Med Genomics (2014)

CDK9 Inhibition Induces a Metabolic Switch that Renders Prostate Cancer Cells Dependent on Fatty Acid Oxidation

Por Itkonen, Harri M., Poulose, Ninu, Walker, Suzanne, Mills, Ian G.
Publicado no Neoplasia (2019)

Endosomal Localization and Receptor Dynamics Determine Tyrosine Phosphorylation of Hepatocyte Growth Factor-Regulated Tyrosine Kinase Substrate

Por Urbé, Sylvie, Mills, Ian G., Stenmark, Harald, Kitamura, Naomi, Clague, Michael J.
Publicado em 2000

Calcium channel blocker use and risk of prostate cancer by TMPRSS2:ERG gene fusion status

Por Geybels, Milan S., McCloskey, Karen D., Mills, Ian G., Stanford, Janet L.
Publicado no Prostate (2016)

Inhibition of Endosome Fusion by Wortmannin Persists in the Presence of Activated rab5

Por Jones, Arwyn T., Mills, Ian G., Scheidig, Axel J., Alexandrov, Kirill, Clague, Michael J.
Publicado em 1998

Slug-Dependent Upregulation of L1CAM Is Responsible for the Increased Invasion Potential of Pancreatic Cancer Cells following Long-Term 5-FU Treatment

Por Lund, Kaja, Dembinski, Jennifer L., Solberg, Nina, Urbanucci, Alfonso, Mills, Ian G., Krauss, Stefan
Publicado no PLoS One (2015)

Bromodomain protein 4 discriminates tissue-specific super-enhancers containing disease-specific susceptibility loci in prostate and breast cancer

Por Zuber, Verena, Bettella, Francesco, Witoelar, Aree, Andreassen, Ole A., Mills, Ian G., Urbanucci, Alfonso
Publicado no BMC Genomics (2017)

Inhibition of O-GlcNAc transferase activates tumor-suppressor gene expression in tamoxifen-resistant breast cancer cells

Por Barkovskaya, Anna, Seip, Kotryna, Prasmickaite, Lina, Mills, Ian G., Moestue, Siver A., Itkonen, Harri M.
Publicado no Sci Rep (2020)

Huntingtin interacting protein 1 modulates the transcriptional activity of nuclear hormone receptors

Por Mills, Ian G., Gaughan, Luke, Robson, Craig, Ross, Theodora, McCracken, Stuart, Kelly, John, Neal, David E.
Publicado em 2005

High OGT activity is essential for MYC-driven proliferation of prostate cancer cells

Por Itkonen, Harri M, Urbanucci, Alfonso, Martin, Sara ES, Khan, Aziz, Mathelier, Anthony, Thiede, Bernd, Walker, Suzanne, Mills, Ian G
Publicado no Theranostics (2019)

New androgen receptor genomic targets show an interaction with the ETS1 transcription factor

Por Massie, Charles E, Adryan, Boris, Barbosa-Morais, Nuno L, Lynch, Andy G, Tran, Maxine G, Neal, David E, Mills, Ian G
Publicado em 2007

Elevated NCOR1 disrupts a network of dietary-sensing nuclear receptors in bladder cancer cells

Por Abedin, S. Asad, Thorne, James L., Battaglia, Sebastiano, Maguire, Orla, Hornung, Laura B., Doherty, Alan P., Mills, Ian G., Campbell, Moray J.
Publicado em 2009

Androgen receptor driven transcription in molecular apocrine breast cancer is mediated by FoxA1

Por Robinson, Jessica L L, MacArthur, Stewart, Ross-Innes, Caryn S, Tilley, Wayne D, Neal, David E, Mills, Ian G, Carroll, Jason S
Publicado em 2011

Androgen receptor driven transcription in molecular apocrine breast cancer is mediated by FoxA1

Por Robinson, Jessica L L, MacArthur, Stewart, Ross-Innes, Caryn S, Tilley, Wayne D, Neal, David E, Mills, Ian G, Carroll, Jason S
Publicado em 2012

Pro-neural transcription factors as cancer markers

Por Vias, Maria, Massie, Charlie E, East, Philip, Scott, Helen, Warren, Anne, Zhou, Zongxiang, Nikitin, Alexander Yu, Neal, David E, Mills, Ian G
Publicado em 2008

Inhibition of O-GlcNAc transferase activity reprograms prostate cancer cell metabolism

Por Itkonen, Harri M., Gorad, Saurabh S., Duveau, Damien Y., Martin, Sara E.S., Barkovskaya, Anna, Bathen, Tone F., Moestue, Siver A., Mills, Ian G.
Publicado no Oncotarget (2016)